Breast Ultrasound Market Size By Product Type (Conventional Ultrasound, Automated Ultrasound), By End-use (Hospitals, Diagnostics Laboratories) – Global Forecast to 2032

Breast Ultrasound Market Size By Product Type (Conventional Ultrasound, Automated Ultrasound), By End-use (Hospitals, Diagnostics Laboratories) – Global Forecast to 2032

Breast Ultrasound Market Size

Breast Ultrasound Market size was valued at over USD 2 billion in 2022 and is projected to reach more than USD 5 billion by 2032. Breast ultrasound is a non-invasive diagnostic ultrasound technique that uses high-frequency sound waves to produce images of the breast tissue. It is commonly used to detect abnormalities such as cysts, lumps, and breast cancer.
 

The market includes various products such as ultrasound systems, probes, as well as accessories. Moreover, growing awareness regarding early diagnosis in response to the launch of various breast cancer awareness programs will positively impact the market expansion. The number of women undergoing breast cancer screening has increased considerably over the years, thereby impelling the demand for breast ultrasound.
 

Additionally, rapid technological advancements in breast ultrasound will create a paradigm shift in the medical imaging industry. Manufacturers are presently focused on introducing innovative breast ultrasound products in the market, thereby bolstering industry size in the forthcoming years. In addition, several market players are emphasizing on research and development activities for the development of novel breast ultrasound will accelerate industry expansion.
 

COVID-19 Impact

COVID-19 significantly impacted the world economy and negatively affected almost every industry and organization, irrespective of its size. Initially, the market suffered a setback due to the commencement of the lockdown and stringent regulations imposed by the authorities during the lockdown. Due to a shortage of both non-essential and vital medical devices and supplies, the pandemic caused chaos in the medical sector as a whole. In addition, the worldwide supply chain was disrupted, impacting the production and shipping of breast ultrasound systems.
 

Breast Ultrasound Market Trends

Technological advancements for the development of novel breast ultrasound systems is anticipated to stimulate market development. The availability of advanced technologies for dense breast tissue scanning as well as the detection of small cancer tumors at an early stage will accelerate industry trends. Market players operating in developed nations are offering innovative technologies that will propel market growth potential. For instance, in May 2022, the FDA approved the world’s first automated and wearable 3D breast ultrasound system, called the ATUSA System from iSono Health, Inc. This breast imaging device offers point-of-care service to patients along with a comfortable experience, enhanced efficiency, and high accuracy. Thus, such initiatives will lead to high product demand in the near future.
 

Breast Ultrasound Market Analysis

Based on product type, the breast ultrasound market is segmented into conventional ultrasound and automated ultrasound. Automated breast ultrasound segment is anticipated to exhibit enormous growth over the estimated period. The growth can be attributed to increasing adoption of automated breast ultrasound (ABUS) devices. These devices use computer-aided detection (CAD) software to produce a 3D image of the breast, which allows for a more comprehensive evaluation of breast tissue and increases the accuracy level of detecting breast cancer. Automated ultrasound devices are particularly useful in combination with traditional mammography screening to provide additional information for a more thorough evaluation, thereby stimulating product adoption.
 

The breast ultrasound market is segmented by end-use into hospitals, diagnostic laboratories, and others. The hospital segment is projected to witness substantial market growth over the forecast period. The demand for breast ultrasound systems has increased remarkably over recent years especially owing to the increasing prevalence of breast cancer worldwide. Hospitals are incorporating breast ultrasound technology into their cancer screening and diagnostic services, utilizing the latest trends to provide more accurate, efficient, and accessible breast cancer screening and diagnostic services to their patients bolstering segment growth potential.
 

U.S. breast ultrasound market accounted for more than USD 825 million in 2022 and will grow momentously more than USD 1694 million by 2032. The affordability of breast ultrasound devices among the target population base and ongoing technological developments are primarily responsible for the growth of the regional market. Further, the region's high healthcare spending on health care management and rising disposable income will propel the expansion of the North America market. Also, the substantial presence of well-established market participants and the favourable regulatory environment result in a number of product approvals and launches, particularly in the U.S.
 

Breast Ultrasound Market Share

Some of the notable key industry players operating in the breast ultrasound market include

• CapeRay Medical
• Delphinus Medical Technologies, Inc
• General Electric Company
• Hitachi, Ltd.
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• Canon Medical Systems Corporation
• Fukuda Denshi
• Hologic; Inc.
• Seno Medical Instruments Inc.
• Shenzen Mindray Bio-Medical Electronics Co., Ltd.
• Samung Electronics Co., Ltd.
• FujiFilm Holdings Corporation

These market participants are implementing various growth strategies such as collaborations, partnerships, acquisitions & mergers, and new product development and launches to strengthen product offerings as well as gain a competitive edge over others.
 

Breast Ultrasound Industry News

• In July 2022, GE Healthcare introduced Invenia Automated Breast Ultrasound (ABUS) 2.0, FDA-approved ultrasound supplemental breast screening device that was created especially for cancer detection in dense breast tissue. The addition further enhanced the company’s portfolio.
   
• In October 2021, Delphinus Medical Technologies, Inc. received premarket approval for its SoftVue 3D whole breast ultrasound imaging system by U.S. FDA for screening breast cancer among asymptomatic women with dense breasts. This has offered lucrative growth opportunities to the firm.
   

 Breast ultrasound market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Product Type (USD Million)

• Conventional ultrasound
• Automated ultrasound        

By End-use (USD Million)

• Hospitals
• Diagnostic laboratories
• Others

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Switzerland
  • Netherlands
  • Czech Republic
  • Poland
  • Belgium
  • Finland
  • Hungary
  • Denmark
  • Ireland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Taiwan
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE